Screener
Eton Pharmaceuticals, Inc. ETON Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $19,661 | $25,942 |
| Accounts receivable, net | 13,408 | 11,757 |
| Inventories, net | 14,467 | 15,419 |
| Prepaid expenses and other current assets | 5,709 | 7,463 |
| Total current assets | 53,245 | 60,581 |
| Property and equipment, net | 372 | 326 |
| Intangible assets, net | 43,738 | 30,878 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s inventories?
- Eton Pharmaceuticals, Inc. (ETON) reported inventories of $14.47M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s inventories changed year-over-year?
- Eton Pharmaceuticals, Inc.'s inventories increased by 6.2% year-over-year, from $13.62M to $14.47M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s inventories?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s inventories has grown at a 111.6% compound annual growth rate (CAGR), from $3.47M to $69.69M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Eton Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude